The partial ergoline LY228729 (1) which was a potent 5HT 1A agonist has been studied clinically. Somewhat later, a related analog, (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine (2a) which in addition to potent 5HT 1A agonist activity was a muscarinic antagonist, was chosen
Synthesis of tritium and deuterium labeled 8-N-n-butyl-N-methylamino-8-(3-hydroxyphenyl)-1,4-dioxaspiro[4,5]decane hydrochloride
โ Scribed by Richard S. P. Hsi; Richard R. Kurtz; Malcolm W. Moon
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 375 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
โฆ Synopsis
The title compound, a 4-amino-4-arylcyclohexanone derivative with central analgesic activit was labeled with tritium at the C-7 and C-9 positions. Deuterium lakeled intermediates were used as models for developing isotope exchange and synthetic procedures. Deuterium and tritium labeled title compounds were obtained in five steps with overall yields of 18-22% from 1,4dioxaspiro[4,S]-decan-8-one and 3bromophenol.
๐ SIMILAR VOLUMES
Synthesis of N-(4-Aryl-1-piperazinylbutyl)-substituted 7,8-Benzo-1,3diazaspiro[4,5]decane-2,4-dione Derivatives with Potential Anxiolytic Activity. -A series of new derivatives of 7,8-benzo-1,3-diazaspirodecane-2,4-dione bearing a piperazinylbutyl group at one imide nitrogen (V) (6 examples) are sy